维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Hoeflich KP"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Requirement for glycogen synthase kinase-3beta in cell survival and NF- kappaB activation 显示文摘	Hoeflich KP Luo J Rubie EA	2000	Nature2000，406，6791：	1
2	Bcl-2 Targeted to the endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblasts 显示文摘	Lee ST Hoeflich KP Wasfy GW	1999	Oncogene1999，18，：	1
3	Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation显示文摘	Hoeflich KP Luo J Rubie EA	2000	Nature2000，406，6791：	1
4	Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-I (askl)显示文摘	Hoeflich KP Yeh WC Yao Z	1999	Oncogene1999，18，42：	1
5	Requirement for glycogen synthase kinase-3beta in cell survival and NF- kappaB activation 显示文摘	Hoeflich KP Luo J Ruhie EA	2000	Nature2000，406，6791：	1
6	Requirement for glycogen synthase kinase-3-beta in cell survival and NF-kappa-B activation 显示文摘	Hoeflich KP Luo J Ruble EA	2000	Nature2000，406，：	1
7	Requirement for glycogensynthase kinase -3(3 in cell survival and NF -kB activation 显示文摘	Hoeflich KP Luo J Rubie EA	2000	Nature2000，406，6791：	1
8	Glycogen synthase kinase- 3 : properties, functions, and regulation显示文摘	Ali A Hoeflich KP Woodgett JR	2001	Chem Rev2001，101，8：	1
9	In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models显示文摘	Hoeflich KP O'brien C Boyd Z		0，，14：	1
10	In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models 显示文摘	Hoeflich KP O'Brien C Boyd Z	2009	Clin Cancer Res2009，15，14：	1
11	Requirement for glycogen syntha- se kinase-3β in cell survival and NF-rB activation显示文摘	Hoeflich KP Luo J Rubie EA etal	2000	Nature2000，406，：	1
12	Requirement for glycogen syn thase kinase-3 beta in cell survival and NF-kappaB activation显示文摘	Hoeflich KP Luo J Rubie EA	2000	Nature2000，406，6791：	1
13	C-Iycogen synthase kinase3: properties, functions, and regulation显示文摘	Ali A Hoeflich KP Woodgett JR	2001	Chem Rev2001，101，8：	1
14	Oncogenic BRAF is required for tumor growth and maintenance in melanoma models 显示文摘	HOEFLICH KP GRAY DC EBY MT	2006	Cancer Res2006，66，2：	1
15	In vivo antitumor activity ofMEK and phosphatidylinositol 3 - kinase inhibitors in basal - likebreast cancer models 显示文摘	Hoeflich KP OBrien C Boyd Z	2009	Clin Cancer Res2009，15，14：	1
16	MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coli显示文摘	Zhang Y Zhang J Hoeflich KP	2003	MolCell2003，12，4：	1
17	Calmodulin in action: Diversity in target recognition and activation mechanisms显示文摘	Hoeflich KP IkuraM	2002	CeR2002，108，6：	1
18	In vivo antiturnor activi- ty of MEK and phosphatidylinositol 3-kinase inhibitors in bas- al-like breast cancer models显示文摘	Hoeflich KP O'Brien C Boyd Z	2009	Clin Cancer Res2009，15，14：	1
19	In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibi- tors in basal-like breast cancer models 显示文摘	Hoeflich KP O'Brien C Boyd Z	2009	Clin Cancer Res2009，15，14：	1
20	Glycogen synthase kinase-3:properties,function,and regulation显示文摘	Hoeflich KP Woodgett JR	2001	Chem Rev2001，101，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示